DWP-450

Mark Your Calendar For These February PDUFA Dates
Yahoo/Benzinga
Sat, 02/2/19 - 12:31 pm
FDA
DWP-450
Evolus
MOTIF BIO PLC/S ADR
Iclaprim
Bausch Health
Duobrii
Merck
Keytruda
Incyte
Novartis
ruxolitinib
Novo Nordisk
N8-GP
Boasting a late-stage Botox me-too, Evolus files for $75M IPO
Endpoints
Tue, 01/9/18 - 04:40 pm
Evolus
Botox
Allergan
IPOs
DWP-450
biosimilars